{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:00:46Z","timestamp":1781650846026,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Robotic Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The prognostic relevance of surgical staging in patients with high-intermediate-risk and high-risk endometrial cancer remains uncertain. In this cohort study, we investigated the prognostic role of robot-assisted laparoscopic staging surgery among patients with clinically early-stage endometrial carcinoma at a high-intermediate-risk or high-risk for recurrence. Clinical data of women with clinically International Federation of Gynaecology and Obstetrics (FIGO) 2009 stage I\u2013II, grade 3 endometrioid or non-endometrioid EC who were intended to undergo robot-assisted laparoscopic staging surgery were retrospectively collected from a single tertiary referral center. The procedure consisted of total hysterectomy with bilateral salpingo-oophorectomy, pelvic lymphadenectomy, and, when feasible, para-aortic lymphadenectomy, with additional omentectomy and peritoneal biopsies performed in a subset of cases. Survival outcomes were assessed using Kaplan\u2013Meier analysis, with additional subgroup analyses by histological subtype. A total of 166 patients, of which 154 patients (92.8%) with FIGO 2009 stage I and 12 patients (7.2%) with FIGO 2009 stage II were included, comprising various histological subtypes, including 64 (38.6%) with endometrioid carcinoma, 52 (31.3%) with serous carcinoma, 11 (6.6%) with clear cell carcinoma, and 27 (16.3%) with carcinosarcoma. Thirty-two patients (19.3%) were reclassified as having FIGO stage disease III\u2013IV based on final pathology. The 5-year disease-specific survival was 25.5% for upstaged patients compared with 73.1% for those who were not upstaged. Robot-assisted laparoscopic staging provides valuable prognostic information in clinically early-stage endometrial cancer with a high-intermediate-risk or high-risk of recurrence. These findings underscore the value of surgical staging in informing prognosis and guiding adjuvant treatment decisions.<\/jats:p>","DOI":"10.1007\/s11701-026-03316-6","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T07:48:01Z","timestamp":1777276081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term prognostic value of staging surgery for high-intermediate-risk and high-risk endometrial cancer"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6314-3031","authenticated-orcid":false,"given":"Alise","family":"de Jong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7429-1766","authenticated-orcid":false,"given":"Jasper","family":"Markus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1829-7773","authenticated-orcid":false,"given":"Ronald P.","family":"Zweemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob P.","family":"Hoogendam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6586-0405","authenticated-orcid":false,"given":"Judith M.","family":"Roesink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4712-9963","authenticated-orcid":false,"given":"Inge O.","family":"Baas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geertruida N.","family":"Jonges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0490-2258","authenticated-orcid":false,"given":"Cornelis G.","family":"Gerestein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"3316_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.annonc.2022.05.009","volume":"33","author":"A Oaknin","year":"2022","unstructured":"Oaknin A, Bosse TJ, Creutzberg CL, Giornelli G, Harter P, Joly F et al (2022) Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 33:860\u2013877. https:\/\/doi.org\/10.1016\/j.annonc.2022.05.009","journal-title":"Ann Oncol"},{"key":"3316_CR2","unstructured":"Cancer Today (2022) [Internet]. World Health Organization. Available from: https:\/\/gco.iarc.fr\/today\/en\/dataviz\/tables?mode=cancer&group_populations=1&multiple_populations=1"},{"key":"3316_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"3316_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx214","author":"J Lortet-Tieulent","year":"2018","unstructured":"Lortet-Tieulent J, Ferlay J, Bray F, Jemal A (2018) International Patterns and Trends in Endometrial Cancer Incidence, 1978\u20132013. JNCI J National Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djx214","journal-title":"JNCI J National Cancer Inst"},{"key":"3316_CR5","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/s0140-6736(22)00323-3","volume":"399","author":"EJ Crosbie","year":"2022","unstructured":"Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N (2022) Endometrial cancer. Lancet 399:1412\u20131428. https:\/\/doi.org\/10.1016\/s0140-6736(22)00323-3","journal-title":"Lancet"},{"key":"3316_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt353","author":"N Colombo","year":"2013","unstructured":"Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C et al (2013) Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals Oncol. https:\/\/doi.org\/10.1093\/annonc\/mdt353","journal-title":"Annals Oncol"},{"key":"3316_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/ijgo.14923","volume":"162","author":"JS Berek","year":"2023","unstructured":"Berek JS, Matias\u2010Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S et al (2023) FIGO staging of endometrial cancer: 2023. Int J Gynaecol Obstet 162:383\u2013394. https:\/\/doi.org\/10.1002\/ijgo.14923","journal-title":"Int J Gynaecol Obstet"},{"key":"3316_CR8","unstructured":"Gynaecologie NVvO (2021) Richtlijn Endometriumcarcinoom. Federatie Medisch Specialisten. Available from: https:\/\/richtlijnendatabase.nl\/richtlijn\/endometriumcarcinoom\/algemeen.html"},{"key":"3316_CR9","doi-asserted-by":"crossref","unstructured":"Morrison J, Balega J, Buckley L, Clamp A, Crosbie E, Drew Y et al (2021) British Gynaecological Cancer Society (BGCS) Uterine Cancer Guidelines - Recommendations for Practice. Eur J Obstet Gynecol Reprod Biol. 2022 Mar;270:50-89. https:\/\/doi.org\/10.1016\/j.ejogrb.2021.11.423.","DOI":"10.1016\/j.ejogrb.2021.11.423"},{"key":"3316_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00428-020-03007-z","volume":"478","author":"N Concin","year":"2021","unstructured":"Concin N, Creutzberg CL, Vergote I, Cibula D, Mirza MR, Marnitz S et al (2021) ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Virchows Arch 478:153\u2013190. https:\/\/doi.org\/10.1007\/s00428-020-03007-z","journal-title":"Virchows Arch"},{"key":"3316_CR11","first-page":"12","volume":"3","author":"C Marth","year":"2015","unstructured":"Marth C, Panici PB (2015) Lymphadenectomy in endometrial cancer for and against. Cancer Breaking News 3:12\u201318","journal-title":"Cancer Breaking News"},{"key":"3316_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.6004\/jnccn.2018.0006","volume":"16","author":"WJ Koh","year":"2018","unstructured":"Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR et al (2018) Uterine neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 16:170\u2013199. https:\/\/doi.org\/10.6004\/jnccn.2018.0006","journal-title":"J Natl Compr Canc Netw"},{"key":"3316_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/annonc\/mdv484","volume":"27","author":"N Colombo","year":"2016","unstructured":"Colombo N, Creutzberg C, Amant F, Bosse T, Gonz\u00e1lez-Mart\u00edn A, Ledermann J, Marth C, Nout R, Querleu D, Mirza MR, Sessa C (2016) ESMO-ESGO-ESTRO consensus conference on endometrial cancer diagnosis treatment and follow-up. Annals Oncol 27:16\u201341.\u00a0https:\/\/doi.org\/10.1097\/IGC.0000000000000609","journal-title":"Annals Oncol"},{"key":"3316_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-002230","author":"N Concin","year":"2021","unstructured":"Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S et al (2021) ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. https:\/\/doi.org\/10.1136\/ijgc-2020-002230","journal-title":"Int J Gynecol Cancer"},{"key":"3316_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jmig.2023.12.010","volume":"31","author":"A de Jong","year":"2024","unstructured":"de Jong A, Baeten IGT, Jansen A, Hoogendam JP, Jurgenliemk-Schulz IM, Zweemer RP et al (2024) Symptomatic lymphocele after robot-assisted pelvic lymphadenectomy as part of the primary surgical treatment for cervical and endometrial cancer: a retrospective cohort study. J Minim Invasive Gynecol 31:243\u20139 e2. https:\/\/doi.org\/10.1016\/j.jmig.2023.12.010","journal-title":"J Minim Invasive Gynecol"},{"key":"3316_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147742","author":"P Ribeiro-Santos","year":"2024","unstructured":"Ribeiro-Santos P, Martins Vieira C, Viana Veloso GG, Vieira Giannecchini G, ParenzaArenhardt M, Muller Gomes L et al (2024) Tailoring endometrial cancer treatment based on molecular pathology: current status and possible impacts on systemic and local treatment. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25147742","journal-title":"Int J Mol Sci"},{"key":"3316_CR17","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S1470-2045(19)30395-X","volume":"20","author":"SM de Boer","year":"2019","unstructured":"de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C et al (2019) Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial. Lancet Oncol 20:1273\u20131285. https:\/\/doi.org\/10.1016\/S1470-2045(19)30395-X","journal-title":"Lancet Oncol"},{"key":"3316_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ygyno.2023.01.022","volume":"170","author":"A Jansen","year":"2023","unstructured":"Jansen A, de Jong A, Hoogendam JP, Baeten IGT, Jurgenliemk-Schulz IM, Zweemer RP et al (2023) Lymphocele following lymph node dissection in cervical and endometrial cancer: A systematic review and meta-analysis. Gynecol Oncol 170:273\u2013281. https:\/\/doi.org\/10.1016\/j.ygyno.2023.01.022","journal-title":"Gynecol Oncol"},{"key":"3316_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ijgo.12073","volume":"136","author":"KJ Pulman","year":"2017","unstructured":"Pulman KJ, Dason ES, Philp L, Bernardini MQ, Ferguson SE, Laframboise S et al (2017) Comparison of three surgical approaches for staging lymphadenectomy in high-risk endometrial cancer. Int J Gynaecol Obstet 136:315\u2013319. https:\/\/doi.org\/10.1002\/ijgo.12073","journal-title":"Int J Gynaecol Obstet"},{"key":"3316_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jmig.2020.12.025","volume":"28","author":"EC Rossi","year":"2021","unstructured":"Rossi EC, Tanner E (2021) Controversies in Sentinel Lymph Node Biopsy for Gynecologic Malignancies. J Minim Invasive Gynecol 28:409\u2013417. https:\/\/doi.org\/10.1016\/j.jmig.2020.12.025","journal-title":"J Minim Invasive Gynecol"},{"key":"3316_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.580128","volume":"10","author":"Y Gu","year":"2020","unstructured":"Gu Y, Cheng H, Zong L, Kong Y, Xiang Y (2020) Operative and oncological outcomes comparing sentinel node mapping and systematic lymphadenectomy in endometrial cancer staging: meta-analysis with trial sequential analysis. Front Oncol 10:580128. https:\/\/doi.org\/10.3389\/fonc.2020.580128","journal-title":"Front Oncol"},{"key":"3316_CR22","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ygyno.2019.03.254","volume":"153","author":"G Bogani","year":"2019","unstructured":"Bogani G, Murgia F, Ditto A, Raspagliesi F (2019) Sentinel node mapping vs. lymphadenectomy in endometrial cancer: A systematic review and meta-analysis. Gynecol Oncol 153:676\u2013683. https:\/\/doi.org\/10.1016\/j.ygyno.2019.03.254","journal-title":"Gynecol Oncol"},{"key":"3316_CR23","doi-asserted-by":"publisher","DOI":"10.23736\/s0026-4784.17.04179-x","author":"JA How","year":"2018","unstructured":"How JA, O\u2019Farrell P, Amajoud Z, Lau S, Salvador S, How E et al (2018) Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis. Minerva Ginecol. https:\/\/doi.org\/10.23736\/s0026-4784.17.04179-x","journal-title":"Minerva Ginecol"},{"key":"3316_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ajog.2016.11.1033","volume":"216","author":"AJ Bodurtha Smith","year":"2017","unstructured":"Bodurtha Smith AJ, Fader AN, Tanner EJ (2017) Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis. Am J Obstet Gynecol 216:459\u201376.e10. https:\/\/doi.org\/10.1016\/j.ajog.2016.11.1033","journal-title":"Am J Obstet Gynecol"},{"key":"3316_CR25","doi-asserted-by":"publisher","DOI":"10.21037\/gs-20-807","author":"Q Ji","year":"2020","unstructured":"Ji Q, Wang X, Jiang J, Chen L (2020) Sentinel lymph node mapping in high-risk endometrial cancer:a systematic review and meta-analysis. Gland Surg. https:\/\/doi.org\/10.21037\/gs-20-807","journal-title":"Gland Surg"},{"key":"3316_CR26","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1055\/s-0042-1749067","volume":"44","author":"MAG Mari\u00f1o","year":"2022","unstructured":"Mari\u00f1o MAG (2022) Sentinel Lymph Node Biopsy in Endometrial Cancer - A Systematic Review and Quality Assessment of Meta-Analyses. Rev Bras Ginecol Obstet 44:785\u2013789. https:\/\/doi.org\/10.1055\/s-0042-1749067","journal-title":"Rev Bras Ginecol Obstet"},{"key":"3316_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ygyno.2024.01.049","volume":"182","author":"SM Bj\u00f8rnholt","year":"2024","unstructured":"Bj\u00f8rnholt SM, Mogensen O, Bouchelouche K, Sponholtz SE, Parner ET, Hildebrandt MG et al (2024) Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study. Gynecol Oncol 182:179\u2013187. https:\/\/doi.org\/10.1016\/j.ygyno.2024.01.049","journal-title":"Gynecol Oncol"},{"key":"3316_CR28","doi-asserted-by":"publisher","first-page":"e1381","DOI":"10.1634\/theoncologist.2019-0113","volume":"24","author":"L Ye","year":"2019","unstructured":"Ye L, Li S, Lu W, He Q, Li Y, Li B et al (2019) A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High-Risk Subtypes? Oncologist 24:e1381\u2013e1387. https:\/\/doi.org\/10.1634\/theoncologist.2019-0113","journal-title":"Oncologist"},{"key":"3316_CR29","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s11864-022-00999-5","volume":"23","author":"R Yu","year":"2022","unstructured":"Yu R, Matthews BJ, Beavis AL (2022) The role of sentinel lymph node mapping in high-grade endometrial cancer. Curr Treat Options Oncol 23:1339\u20131352. https:\/\/doi.org\/10.1007\/s11864-022-00999-5","journal-title":"Curr Treat Options Oncol"},{"key":"3316_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001964","author":"LC Burg","year":"2021","unstructured":"Burg LC, Hengeveld EM, In\u2018t Hout J, Bulten J, Bult P, Zusterzeel PLM (2021) Ultrastaging methods of sentinel lymph nodes in endometrial cancer - a systematic review. Int J Gynecol Cancer. https:\/\/doi.org\/10.1136\/ijgc-2020-001964","journal-title":"Int J Gynecol Cancer"},{"key":"3316_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2022.02.003","author":"N Jebens Nordskar","year":"2022","unstructured":"Jebens Nordskar N, Hagen B, Vesterfjell EV, Salvesen \u00d8, Aune G (2022) Long-term outcome in endometrial cancer patients after robot-assisted laparoscopic surgery with sentinel lymph node mapping. Eur J Obstet Gynecol Reprod Biol. https:\/\/doi.org\/10.1016\/j.ejogrb.2022.02.003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3316_CR32","first-page":"323","volume":"11","author":"V Cela","year":"2020","unstructured":"Cela V, Sergiampietri C, Rosa Obino ME, Bifulco G, Giovanni Artini P, Papini F (2020) Sentinel-lymph-node mapping with indocyanine green in robotic-assisted laparoscopic surgery for early endometrial cancer: a retrospective analysis. Facts Views Vis Obgyn 11:323\u2013328","journal-title":"Facts Views Vis Obgyn"},{"key":"3316_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9123874","author":"L Lecointre","year":"2020","unstructured":"Lecointre L, Lodi M, Faller \u00c9, Boisram\u00e9 T, Agnus V, Baldauf JJ et al (2020) Diagnostic accuracy and clinical impact of sentinel lymph node sampling in endometrial cancer at high risk of recurrence: a meta-analysis. J Clin Med. https:\/\/doi.org\/10.3390\/jcm9123874","journal-title":"J Clin Med"},{"key":"3316_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.654285","volume":"11","author":"VG Pineda","year":"2021","unstructured":"Pineda VG, Zapardiel I, Gracia M, Siegrist J, Diestro MD, Alonso M et al (2021) Avoiding full lymphadenectomies in intermediate- and high-risk endometrial cancer by sentinel lymph node biopsy implementation. Front Oncol 11:654285. https:\/\/doi.org\/10.3389\/fonc.2021.654285","journal-title":"Front Oncol"}],"container-title":["Journal of Robotic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-026-03316-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11701-026-03316-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-026-03316-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:47:16Z","timestamp":1781650036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11701-026-03316-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3316"],"URL":"https:\/\/doi.org\/10.1007\/s11701-026-03316-6","relation":{},"ISSN":["1863-2491"],"issn-type":[{"value":"1863-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ronald P. Zweemer is a proctor for robot-assisted surgery in gynaecological oncology on behalf of Intuitive Surgical.\u00a0The authors declare no further financial or non-financial conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The protocol was reviewed in accordance with institutional guidelines and classified as exempt from Institutional Review Board approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"468"}}